These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35908202)

  • 1. A novel role of helix-loop-helix transcriptional factor Bhlhe40 in osteoclast activation.
    Hirata H; Kamohara A; Murayama M; Nishioka K; Honda H; Urano Y; Soejima H; Oki S; Kukita T; Kawano S; Mawatari M; Kukita A
    J Cell Physiol; 2022 Oct; 237(10):3912-3926. PubMed ID: 35908202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.
    Okayasu M; Nakayachi M; Hayashida C; Ito J; Kaneda T; Masuhara M; Suda N; Sato T; Hakeda Y
    J Biol Chem; 2012 Jun; 287(23):19229-41. PubMed ID: 22500026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PMEPA1 and NEDD4 control the proton production of osteoclasts by regulating vesicular trafficking.
    Hirata H; Xu X; Nishioka K; Matsuhisa F; Kitajima S; Kukita T; Murayama M; Urano Y; Miyamoto H; Mawatari M; Kukita A
    FASEB J; 2021 Feb; 35(2):e21281. PubMed ID: 33484199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pim-2 regulates bone resorptive activity of osteoclasts via V-ATPase a3 isoform expression in periodontal disease.
    Heo SC; You JC; Jung S; Kim YN; Shin SH; Lee JY; Kim HJ
    J Cell Physiol; 2022 Aug; 237(8):3381-3393. PubMed ID: 35696529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption.
    Wu H; Xu G; Li YP
    J Bone Miner Res; 2009 May; 24(5):871-85. PubMed ID: 19113919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts.
    Feng S; Deng L; Chen W; Shao J; Xu G; Li YP
    Biochem J; 2009 Jan; 417(1):195-203. PubMed ID: 18657050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.
    Mattson AM; Begun DL; Molstad DHH; Meyer MA; Oursler MJ; Westendorf JJ; Bradley EW
    J Biol Chem; 2019 Aug; 294(31):11772-11784. PubMed ID: 31189651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
    Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
    J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
    Ma J; Zhu L; Zhou Z; Song T; Yang L; Yan X; Chen A; Ye TW
    Cell Prolif; 2021 Jan; 54(1):e12955. PubMed ID: 33159483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAF family member-associated NF-κB activator (TANK) induced by RANKL negatively regulates osteoclasts survival and function.
    Wu M; Wang Y; Deng L; Chen W; Li YP
    Int J Biol Sci; 2012; 8(10):1398-407. PubMed ID: 23139637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of osteoclastogenesis by RNA interference targeting RANK.
    Ma R; Xu J; Dong B; Kauther MD; Jäger M; Wedemeyer C
    BMC Musculoskelet Disord; 2012 Aug; 13():154. PubMed ID: 22913338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.
    Yang DQ; Feng S; Chen W; Zhao H; Paulson C; Li YP
    J Bone Miner Res; 2012 Aug; 27(8):1695-707. PubMed ID: 22467241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities.
    Joung YH; Darvin P; Kang DY; Sp N; Byun HJ; Lee CH; Lee HK; Yang YM
    PLoS One; 2016; 11(7):e0159891. PubMed ID: 27447722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.
    Park OJ; Kim J; Kim HY; Kwon Y; Yun CH; Han SH
    Microb Pathog; 2019 Jan; 126():218-223. PubMed ID: 30414445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of Stabilin-1 Enhances Bone-Resorbing Activity in Osteoclasts In Vitro.
    Kim SY; Lee EH; Park SY; Choi H; Koh JT; Park EK; Kim IS; Kim JE
    Calcif Tissue Int; 2019 Aug; 105(2):205-214. PubMed ID: 31025051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipase C-related, but catalytically inactive protein (PRIP) up-regulates osteoclast differentiation via calcium-calcineurin-NFATc1 signaling.
    Murakami A; Matsuda M; Harada Y; Hirata M
    J Biol Chem; 2017 May; 292(19):7994-8006. PubMed ID: 28341745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
    Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
    J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo.
    Liu FL; Chen CL; Lai CC; Lee CC; Chang DM
    Phytomedicine; 2020 Apr; 69():153195. PubMed ID: 32200293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the proton receptor OGR1 in mouse osteoclasts impairs metabolic acidosis-induced bone resorption.
    Krieger NS; Chen L; Becker J; Chan MR; Bushinsky DA
    Kidney Int; 2021 Mar; 99(3):609-619. PubMed ID: 33159961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.